Institute for Immunity, Transplantation and Infection

ITI Associate Directors

Carlos Equivel, MD, PhD
Associate Director, Institute for Immunity, Transplantation and Infection

Carlos O. Esquivel is The Arnold and Barbara Silverman Professor of Pediatric Transplantation and Professor of Surgery at Stanford University School of Medicine.  He is Chief of the Division of Abdominal Transplantation and Director of the Liver Transplant and Intestinal Programs at Lucile Salter Packard Children’s Hospital at Stanford (LPCH). He is also Associate Director of the Institute of Immunity, Transplantation and Infection. He received his M.D. degree from the University of Costa Rica School of Medicine, completed general surgery training at the University of California Davis and then obtained a doctoral degree from the University of Lund in Sweden.  He trained in transplantation at the University of Pittsburgh under the direction of Dr. Thomas Starzl. In 1988, Dr. Esquivel founded the highly successful Liver Transplant Program at California Pacific Medical Center (formerly known as Pacific Presbyterian Medical Center) in San Francisco. He was then recruited to Stanford in 1995 to start the Pediatric Liver Transplant Program at LPCH. Dr. Esquivel is recognized worldwide as an expert and pioneer in transplantation, specifically in transplantation of children under 1 year of age.  He has introduced novel techniques to alleviate the problem of organ shortage such as liver reductions, split liver transplantation and living-related liver transplantation.  He is a creative and productive investigator having contributed 325 publications in scientific journals and given close to 200 lectures throughout United States and internationally. Dr. Esquivel also oversees multiple basic science and clinical research projects which seek to advance the field of transplantation and improve the lives of transplant patients and their families.

Garry Fathman, MD
Associate Director of Autoimmunity

Garry Fathman, MD

Dr. C. Garrison (Garry) Fathman, Founder and Past President of the Federation of Clinical Immunology Societies (FOCIS), Professor of Medicine in the Division of Immunology and Rheumatology at Stanford University School of Medicine, also serves as Director of the Center for Clinical Immunology at Stanford (CCIS).

Dr. Fathman¹s contributions in the cellular and molecular immunology of CD4 T cells, and adoptive cellular gene therapy, have brought him international recognition. In particular, he is acclaimed for his establishment and exploitation of the technologies of antigen-specific T-cell cloning and adoptive cellular gene therapy, accomplishments that have facilitated a remarkable series of subsequent advances in understanding conventional immune response and provided insights into future therapy of autoimmune diseases.

As Founder and past President of FOCIS, Dr. Fathman led an extremely successful international effort to acknowledge and develop the field of clinical immunology. As Director of the CCIS, the Stanford-based FOCIS Center of Excellence, Dr. Fathman has initiated multi-disciplinary studies to generate novel approaches for the study of autoimmune diseases, including insulin-dependent diabetes mellitus, rheumatoid arthritis, and multiple sclerosis. He has also applied state-of-the-art technologies of genomics, proteomics, and bioinformatics to integrate approaches to diagnosis, prognosis, and therapy of these diseases.

After receiving his M.D. from Washington University in St. Louis, Dr. Fathman did his residency training at Dartmouth Affiliated Hospitals and completed a fellowship in immunology and rheumatology at Stanford University. He then spent four years doing bench research, first as a Clinical Associate at the Immunology Branch of the National Cancer Institute of the National Institutes of Health and subsequently as a Member of the Basel Institute of Immunology in Switzerland. He returned to the United States to join the faculty as Associate Professor of Immunology at the Mayo Clinic in 1977 and was recruited to Stanford School of Medicine as an Associate Professor in 1981.

Dr. Fathman is a member of many professional organizations, including the Association of American Physicians, American Society of Clinical Investigation (past Council member) and the American Association of Immunologists, and is the Past-President of the Clinical Immunology Society. He was associate editor of the prestigious Annual Review of Immunology for 25 years and serves on the editorial boards of numerous scientific journals. In addition, he has chaired a variety of national and international professional meetings and has written more than 250 articles on his research. Dr. Fathman has served as Chairman of two NIH study sections and currently serves on the governing council of TrialNet (a group of clinician scientists looking at the prevention and early treatment of type 1 diabetes) and as past Chairman of the autoimmune disease section of the Immune Tolerance Network.

P.J. Utz, MD
Associate Director of Education

While earning his M.D. degree in 1991 from Stanford, Dr. Utz co-discovered the transcription factor Nuclear Factor of Activated T Cells (NFAT) with J.P. Shaw in Dr. Gerald Crabtree's laboratory. He completed his internal medicine residency, rheumatology fellowship, and post-doctoral training at Brigham and Women's Hospital in Boston prior to joining the Harvard Medical School Faculty in 1996. He joined the Stanford Faculty in 1999 and was promoted to Associate Professor of Medicine in 2005 and Professor in 2012. Professor Utz is an expert in the study of human and murine autoantibodies and autoantigens, apoptosis signaling pathways, animal models of autoimmunity, proteomics and multiplexed assay development for biomarker discovery.

Members of his laboratory are developing several cutting-edge proteomics technologies for immunological applications, including multiplex planar-based autoantigen microarrays for studying lupus, multiple sclerosis, and other diseases such as diabetes and MCTD; reverse phase protein lysate microarrays for studying blood cells; flow-based assays for analyzing samples from patients; and microfluidic capillary electrophoresis assays.  Professor Utz is Founder and Faculty Director of the SIMR Summer High School Research Program, retired Chair of Education for the Federation of Clinical Immunology Societies, and assumed the role of Director of Stanford's Medical Scientist Training Program (MSTP) in August 2013. He provides formal lectures to undergraduate, graduate, and medical students in the Schools of Medicine and Engineering. He also teaches medical students, residents and fellows in the clinics and on the in-patient wards, and has won teaching awards in immunology and in medicine. Professor Utz is a member of the Scientific Advisory Boards of several biotechnology and pharmaceutical companies, and has cofounded 3 Bay Area companies.

Gary Schoolnik, PhD
Associate Director of Infectious Disease

Gary Schoolnik is Professor of Medicine, Microbiology and Immunology, Associate Director of the Institute for Immunology, Transplantation and Infection, Associate Dean, Academic Affairs, Stanford Medical School and Attending Physician in Internal Medicine and Infectious Diseases, Stanford Medical Center. His research focuses on the genomics and systems biology of tuberculosis and he is P.I. of the TBDatabase project (<>), funded by the Bill and Melinda Gates Foundation and of TBSysBio, an NIH-funded, multi-institutional systems biology project. His laboratory also studies Vibrio cholerae and most recently on single cell expression profiling of this organism in real time and in structured environments, including the intestine and the aquatic habitats which serve as its reservoir in nature.

Stanford Medicine Resources:

Footer Links: